Today: 20 May 2026
Coherent (COHR) stock: big options bets build as Wall Street lifts targets into Feb. 4 earnings

Coherent (COHR) stock: big options bets build as Wall Street lifts targets into Feb. 4 earnings

New York, January 24, 2026, 19:55 (ET) — Market closed

  • Coherent shares dropped 2.9% on Friday, closing at $196.94
  • Late-week options flow tilted sharply toward calls, signaling bullish bets
  • New price-target increases have sharpened focus on the company’s Feb. 4 earnings report

Coherent Corp shares dropped 2.9% on Friday, closing at $196.94, capping off a week marked by volatile moves for the photonics company.

The decline followed a turbulent week on Wall Street: the S&P 500 edged up 0.1% Friday, the Nasdaq added 0.3%, while the Dow dropped 0.6%. All three ended the week with small losses.

Options activity monitored by Benzinga showed a surge in big trades on COHR late Friday—18 calls against just four puts over 22 deals. Recent price targets include $220 from Stifel, $235 from Susquehanna, and $215 at Barclays. Coherent’s top revenue driver remains networking, alongside its materials and lasers divisions.

Calls are contracts giving traders the right to buy shares at a fixed price before a specified date; puts offer the right to sell under the same terms. High call volume may signal a directional wager, act as a hedge, or let traders speculate on a sharp move without holding the stock.

Into the weekend, peers also took a hit: Lumentum dropped 4.4% on Friday, while Ciena slipped 0.4%.

Stifel’s Ruben Roy boosted his price target on Coherent to $220 from $168, maintaining a Buy rating. He noted the company stands out “most favorably” on valuation and near-term execution. TipRanks

Susquehanna’s Christopher Rolland raised his price target to $235 from $160, maintaining a Positive rating. He cited a “steadying upcycle” and a wider AI infrastructure supply chain but noted ongoing pressure on auto demand. TipRanks

Coherent will hold its FY2026 second-quarter earnings webcast on Wednesday, Feb. 4, at 4:30 p.m. EST.

The stock remains close to the high end of its 52-week range, which stretches from $45.58 to $213.30, offering scant margin for a weak report or a guarded forecast.

Bullish positioning faces a risk because options flow often gets noisy — heavy call buying might hide hedges or spreads that don’t actually signal strong optimism. Next week’s Federal Reserve decision and a packed schedule of major earnings could rapidly shift sentiment in growth stocks.

As trading kicks off Monday, eyes will be on whether Friday’s retreat sticks — and if positioning ahead of Feb. 4 signals a clear directional bet or merely sets the stage for some volatility around the print.

Stock Market Today

  • Williams-Sonoma Gains 1.58% as Market Declines, Eyes Upcoming Earnings
    May 19, 2026, 7:31 PM EDT. Williams-Sonoma (WSM) shares rose 1.58% to $171.83, outperforming the S&P 500's 0.67% drop. The stock had declined 16.27% over the past month, lagging the sector's 0.69% loss but behind the S&P 500's 4% gain. Investors await WSM's upcoming earnings report, expected to show $1.80 per share in EPS, down 2.7% year-over-year, with revenue projected to rise 4.25% to $1.8 billion. The company's full-year estimates anticipate 4.75% EPS growth and 4.39% revenue growth. Analyst estimate revisions have nudged EPS projections higher by 0.58% in 30 days, with WSM holding a Zacks Rank #3 (Hold). Valuation indicators show a Forward P/E of 18.27, slightly below industry average, while the PEG ratio of 2.12 exceeds the Retail - Home Furnishings sector average of 1.63.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Goldman Sachs stock slides into Fed week after CEO pay disclosure
Previous Story

Goldman Sachs stock slides into Fed week after CEO pay disclosure

Vallourec’s Delphy hydrogen storage lands Hyvolution award nod as Paris show nears
Next Story

Vallourec’s Delphy hydrogen storage lands Hyvolution award nod as Paris show nears

Go toTop